Alector (ALEC) Amortization of Deferred Charges (2025 - 2026)
Alector (ALEC) reported Amortization of Deferred Charges of $78000.0 for Q1 2026, up 13.04% year-over-year from $69000.0 in Q1 2025, and little changed quarter-over-quarter from $78000.0 in Q4 2025.
Alector (ALEC) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
Alector (ALEC) has 2 years of Amortization of Deferred Charges data on file, last reported at $78000.0 in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $78000.0, up 13.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $302000.0 (up 337.68% YoY), and the FY2025 annual result was $293000.0, changed N/A from the prior year.
- Amortization of Deferred Charges held at $78000.0 in Q1 2026 per ALEC's latest filing, from $78000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $78000.0 in Q4 2025 and troughed at $69000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Mar 31, 2025 | 69,000.00 |